Electromed (NYSE:ELMD) Now Covered by StockNews.com

StockNews.com started coverage on shares of Electromed (NYSE:ELMDGet Rating) in a research report issued to clients and investors on Wednesday. The firm set a “strong-buy” rating on the stock.

Shares of ELMD opened at $12.47 on Wednesday. Electromed has a 52-week low of $8.98 and a 52-week high of $13.85. The firm has a 50 day simple moving average of $12.45. The firm has a market capitalization of $106.41 million, a price-to-earnings ratio of 56.68, a PEG ratio of 4.82 and a beta of 0.62.

Electromed (NYSE:ELMDGet Rating) last issued its quarterly earnings results on Tuesday, February 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.03. Electromed had a return on equity of 5.77% and a net margin of 4.94%. The firm had revenue of $10.25 million for the quarter.

Electromed Company Profile (Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

Featured Articles

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.